Escherichia coli
Resistant to carbapenems, third-generation cephalosporins, and fluoroquinolones
GRAM estimates the global prevalence of Escherichia coli infections with observed resistance to carbapenems, third-generation cephalosporins, and fluoroquinolones over time. Based on a detailed systematic review and statistical analysis, findings are due for release in 2023.